Literature DB >> 23509121

Association between prevalence of chloroquine resistance and unusual mutation in pfmdr-I and pfcrt genes in India.

Sabyasachi Das1, Subhankari Prasad Chakraborty, Amiya Kumar Hati, Somenath Roy.   

Abstract

This study deals with the underlying causes of failure of chloroquine in the treatment of Plasmodium falciparum infection in some malaria-endemic regions of India. Samples were collected from 141 patients in Purulia from March of 2007 to April of 2008. In vitro drug susceptibility tests, parasitic DNA isolation followed by polymerase chain reaction, and restriction fragment-length polymorphisms of different codons of the pfcrt gene (76) and pfmdr-I genes (86, 1042, and 1246) were assessed. The responses of 141 patients to chloroquine were determined. Prevalence of double pfmdr-I (58.16%) mutation (86Y+1246Y) and some (14.89%) single pfcrt mutations with triple pfmdr-I mutation (76T+86Y+1042D+1246Y) were found. Interestingly, double pfmdr-I mutation (86Y and 1246Y codons) was observed with the early treatment failure cases. These results show, for the first time in India that in vitro chloroquine resistance and in vivo chloroquine treatment failure were caused by double pfmdr-I (P < 0.001) mutation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23509121      PMCID: PMC3752744          DOI: 10.4269/ajtmh.11-0795

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  19 in total

1.  Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum.

Authors:  Rajeev K Mehlotra; Gabriel Mattera; Moses J Bockarie; Jason D Maguire; J Kevin Baird; Yagya D Sharma; Michael Alifrangis; Grant Dorsey; Philip J Rosenthal; David J Fryauff; James W Kazura; Mark Stoneking; Peter A Zimmerman
Journal:  Antimicrob Agents Chemother       Date:  2008-04-14       Impact factor: 5.191

2.  Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine.

Authors:  Juliana Martha Sá; Olivia Twu; Karen Hayton; Sahily Reyes; Michael P Fay; Pascal Ringwald; Thomas E Wellems
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-02       Impact factor: 11.205

3.  Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand.

Authors:  G Snounou; X Zhu; N Siripoon; W Jarra; S Thaithong; K N Brown; S Viriyakosol
Journal:  Trans R Soc Trop Med Hyg       Date:  1999 Jul-Aug       Impact factor: 2.184

Review 4.  Contribution of the pfmdr1 gene to antimalarial drug-resistance.

Authors:  Manoj T Duraisingh; Alan F Cowman
Journal:  Acta Trop       Date:  2005-06       Impact factor: 3.112

5.  Chloroquine clinical failures in P. falciparum malaria are associated with mutant Pfmdr-1, not Pfcrt in Madagascar.

Authors:  Valérie Andriantsoanirina; Arsène Ratsimbasoa; Christiane Bouchier; Magali Tichit; Martial Jahevitra; Stéphane Rabearimanana; Rogelin Raherinjafy; Odile Mercereau-Puijalon; Rémy Durand; Didier Ménard
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

6.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

7.  Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility.

Authors:  Valérie Andriantsoanirina; Arsène Ratsimbasoa; Christiane Bouchier; Martial Jahevitra; Stéphane Rabearimanana; Rogelin Radrianjafy; Voahangy Andrianaranjaka; Tantely Randriantsoa; Marie Ange Rason; Magali Tichit; Léon Paul Rabarijaona; Odile Mercereau-Puijalon; Rémy Durand; Didier Ménard
Journal:  Antimicrob Agents Chemother       Date:  2009-08-24       Impact factor: 5.191

8.  Low efficacy of chloroquine: time to switchover to artemisinin-based combination therapy for falciparum malaria in India.

Authors:  N Valecha; H Joshi; P K Mallick; S K Sharma; A Kumar; P K Tyagi; B Shahi; M K Das; B N Nagpal; A P Dash
Journal:  Acta Trop       Date:  2009-02-07       Impact factor: 3.112

9.  Widespread occurrence of the Plasmodium falciparum chloroquine resistance transporter (Pfcrt) gene haplotype SVMNT in P. falciparum malaria in India.

Authors:  P G Vathsala; A Pramanik; S Dhanasekaran; C Usha Devi; C R Pillai; S K Subbarao; S K Ghosh; S N Tiwari; T S Sathyanarayan; P R Deshpande; G C Mishra; M R Ranjit; A P Dash; P N Rangarajan; G Padmanaban
Journal:  Am J Trop Med Hyg       Date:  2004-03       Impact factor: 2.345

10.  Antimalarial drug use in general populations of tropical Africa.

Authors:  Florence Gardella; Serge Assi; Fabrice Simon; Hervé Bogreau; Teunis Eggelte; Fatou Ba; Vincent Foumane; Marie-Claire Henry; Pélagie Traore Kientega; Léonardo Basco; Jean-François Trape; Richard Lalou; Maryse Martelloni; Marc Desbordes; Meïli Baragatti; Sébastien Briolant; Lionel Almeras; Bruno Pradines; Thierry Fusai; Christophe Rogier
Journal:  Malar J       Date:  2008-07-08       Impact factor: 2.979

View more
  7 in total

1.  Simple Molecular Methods for Early Detection of Chloroquine Drug Resistance in Plasmodium vivax and Plasmodium falciparum.

Authors:  Gurjeet Singh; Raksha Singh; Anant Dattatraya Urhehar
Journal:  J Clin Diagn Res       Date:  2016-07-01

2.  Double mutation in the pfmdr1 gene is associated with emergence of chloroquine-resistant Plasmodium falciparum malaria in Eastern India.

Authors:  Sabyasachi Das; Santanu Kar Mahapatra; Satyajit Tripathy; Sourav Chattopadhyay; Sandeep Kumar Dash; Debasis Mandal; Balaram Das; Amiya Kumar Hati; Somenath Roy
Journal:  Antimicrob Agents Chemother       Date:  2014-07-28       Impact factor: 5.191

3.  Artemisinin combination therapy fails even in the absence of Plasmodium falciparum kelch13 gene polymorphism in Central India.

Authors:  Sabyasachi Das; Amrita Kar; Subhankar Manna; Samaresh Mandal; Sayantani Mandal; Subhasis Das; Bhaskar Saha; Amiya Kumar Hati
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

4.  Expression levels of pvcrt-o and pvmdr-1 are associated with chloroquine resistance and severe Plasmodium vivax malaria in patients of the Brazilian Amazon.

Authors:  Gisely C Melo; Wuelton M Monteiro; André M Siqueira; Siuhelem R Silva; Belisa M L Magalhães; Aline C C Alencar; Andrea Kuehn; Hernando A del Portillo; Carmen Fernandez-Becerra; Marcus V G Lacerda
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

5.  Low prevalence of dihydro folate reductase (dhfr) and dihydropteroate synthase (dhps) quadruple and quintuple mutant alleles associated with SP resistance in Plasmodium vivax isolates of West Bengal, India.

Authors:  Sabyasachi Das; Abhijit Banik; Amiya Kumar Hati; Somenath Roy
Journal:  Malar J       Date:  2016-08-02       Impact factor: 2.979

6.  Progressive increase in point mutations associates chloroquine resistance: Even after withdrawal of chloroquine use in India.

Authors:  Sabyasachi Das; Satyajit Tripathy; Sourav Chattopadhayay; Balaram Das; Santanu Kar Mahapatra; Amiya Kumar Hati; Somenath Roy
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-06-29       Impact factor: 4.077

7.  Quantitative characterization of hemozoin in Plasmodium berghei and vivax.

Authors:  John M Pisciotta; Peter F Scholl; Joel L Shuman; Vladimir Shualev; David J Sullivan
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-02-08       Impact factor: 4.077

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.